Biotech raises $102M to bring RNA products to ‘patients and farmers alike’

With a renewed focus on bringing sustainable biopesticides and a coronavirus vaccine to market, GreenLight Biosciences Inc., the rapidly growing agtech and life sciences firm based in Medford, has brought in $102 million in Series D funding.